Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Veenstra

Showing results (71-80 of 264) with videos related to

Pageof 27
Sort By:
The American Journal of Managed Care|February 27, 2026
Do targeted NGS panels include NSCLC guideline-recommended biomarkers?Jade Reynolds, Siyang Peng, Elizabeth Brouwer, et al.
Sexually Transmitted Diseases|February 5, 2003
The clinical and economic consequences of screening young men for genital chlamydial infectionRachel H S Ginocchio, David L Veenstra, Frederick A Connell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2003
Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodineNathorn Chaiyakunapruk, David L Veenstra, Benjamin A Lipsky, et al.
Cancers|February 1, 2018
Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic CancerVeronique L Veenstra, Andrea Garcia-Garijo, Hanneke W van Laarhoven, et al.
Health Economics|June 26, 2019
Do cancer treatments have option value? Real-world evidence from metastatic melanomaMeng Li, Anirban Basu, Caroline S Bennette, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 21, 2010
Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research prioritiesRena Conti, David L Veenstra, Katrina Armstrong, et al.
Molecular Oncology|March 21, 2012
Paying for personalized care: cancer biomarkers and comparative effectivenessRahber Thariani, David L Veenstra, Josh J Carlson, et al.
Archives of Internal Medicine|September 22, 2000
The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infectionS Saint, D L Veenstra, S D Sullivan, et al.
Critical Care Medicine|April 16, 2014
Long-term survival in patients with severe acute respiratory distress syndrome and rescue therapies for refractory hypoxemia*Nita Khandelwal, Catherine L Hough, Aasthaa Bansal, et al.
Urology|October 2, 2012
Psychosocial difficulties in children referred to pediatric urology: a closer lookCortney Wolfe-Christensen, Amy L Veenstra, Larisa Kovacevic, et al.
Pageof 27

Showing results (71-80 of 264) with videos related to

Sort By:
Pageof 27
The American Journal of Managed Care|February 27, 2026
Do targeted NGS panels include NSCLC guideline-recommended biomarkers?Jade Reynolds, Siyang Peng, Elizabeth Brouwer, et al.
Sexually Transmitted Diseases|February 5, 2003
The clinical and economic consequences of screening young men for genital chlamydial infectionRachel H S Ginocchio, David L Veenstra, Frederick A Connell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2003
Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodineNathorn Chaiyakunapruk, David L Veenstra, Benjamin A Lipsky, et al.
Cancers|February 1, 2018
Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic CancerVeronique L Veenstra, Andrea Garcia-Garijo, Hanneke W van Laarhoven, et al.
Health Economics|June 26, 2019
Do cancer treatments have option value? Real-world evidence from metastatic melanomaMeng Li, Anirban Basu, Caroline S Bennette, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 21, 2010
Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research prioritiesRena Conti, David L Veenstra, Katrina Armstrong, et al.
Molecular Oncology|March 21, 2012
Paying for personalized care: cancer biomarkers and comparative effectivenessRahber Thariani, David L Veenstra, Josh J Carlson, et al.
Archives of Internal Medicine|September 22, 2000
The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infectionS Saint, D L Veenstra, S D Sullivan, et al.
Critical Care Medicine|April 16, 2014
Long-term survival in patients with severe acute respiratory distress syndrome and rescue therapies for refractory hypoxemia*Nita Khandelwal, Catherine L Hough, Aasthaa Bansal, et al.
Urology|October 2, 2012
Psychosocial difficulties in children referred to pediatric urology: a closer lookCortney Wolfe-Christensen, Amy L Veenstra, Larisa Kovacevic, et al.
Pageof 27